Highlights d 24,000 HLA class I peptides were identified through a scalable MS-based pipeline.
In Brief
HLA class I binding prediction has traditionally been based on biochemical binding experiments. Abelin and colleagues present an LC-MS/MS-based workflow and analytical framework that greatly accelerates gains in prediction performance. Key advances include the discovery of sequence motifs and improved quantification of the roles of gene expression and proteasomal processing.
INTRODUCTION
Human leukocyte antigen (HLA) class I glycoproteins (HLA-A, -B, and -C) are expressed on the surface of almost all nucleated cells in the human body and are required for presentation of short peptides for detection by T cell receptors. The HLA genes are the most polymorphic genes across the human population; more than 10,000 HLA class I allele variants have been identified to date (Robinson et al., 2015) . Each HLA allele is estimated to bind and present $1,000-10,000 unique peptides to T cells (Hunt et al., 1992; Rammensee et al., 1995; Vita et al., 2015) , less than 0.1% of the estimated 10 million potential 9-mer peptides from human protein-coding genes. Given such diversity in HLA binding, accurate prediction of whether a peptide is likely to bind to a specific HLA allele is highly challenging.
Rules for peptide binding to HLA molecules have been studied extensively for a subset of HLA alleles (Vita et al., 2015) and have been encoded in modern advanced neural-network-based algorithms (Hoof et al., 2009; Lundegaard et al., 2008) . However, the algorithms in common use today (Trolle et al., 2015) are trained almost exclusively on measurements of biochemical affinity of synthetic peptides. This imparts several disadvantages. First, the throughput of these methods is limited because only a very small percentage of peptides are expected to bind, and therefore researchers must synthesize and experimentally assess potentially 1,000s of negative examples to identify 10s of strong-binding positive examples. Biased sampling can improve these odds but carries the risk of skewing the results or missing subdominant motifs. Meanwhile, other unintentional forms of bias, such as pre-existing notions of the length distribution or limitations on peptide synthesis and solubility, are difficult to avoid. Most importantly, these approaches do not necessarily consider the endogenous processing and transport of peptides prior to HLA binding. Mass spectrometry (MS)-based approaches yield a large and relatively unbiased portrait of the population of processed and presented peptides and should (legend continued on next page) theoretically address most of these problems. However, historically liquid chromatography-tandem mass spectrometry (LC-MS/MS) methods have required large cellular input, which limits throughput, and the multi-allelic nature of the data complicates productive motif learning.
In this study, we developed a biochemical and computational pipeline for LC-MS/MS analysis of endogenously processed HLA-associated peptides that requires less input material and provides single-allele resolution. Currently, the only single-allele approach available is based on the isolation of soluble HLA from cell lines grown in bioreactors, a setup that is not straightforward to implement and requires several orders of magnitude more input material (Hawkins et al., 2008; Trolle et al., 2016) . Our approach, which isolates peptides from cells engineered to express a single HLA allele, provides a scalable means to improve the predictive power of algorithms for class I HLA-presented peptides and avoid in silico allelic deconvolution (Bassani-Sternberg and Gfeller, 2016) . Meanwhile, it leverages advances in instrumentation for rapid collection of high-resolution data and database search strategies that dynamically learn and leverage HLA peptide-binding motifs. The combination of direct antigen sequencing by LC-MS/MS and comprehensive bioinformatic analyses enabled the development of a predictor that outperformed current algorithms that are trained on peptide affinity data.
RESULTS

Workflow Uncovers Large Mono-allelic Peptide
Repertoires with Minimal MS Bias HLA-bound peptides can be directly identified via immunopurification and LC-MS/MS. We processed class I HLA-deficient cell lines (30 million-90 million B721.221-derived cells), each stably transduced to express one of 16 different class I HLA alleles (Figures 1A and 1B) . High-quality tandem mass spectra (MS/MS) were subjected to iterative database searches, with stringent quality criteria (Experimental Procedures). The first round used no-enzyme specificity and no-variable peptide modifications, and the second round applied a database digestion specificity that leveraged the peptide-binding motif of individual HLA alleles determined from the first-round results and allowed peptide modifications (Experimental Procedures, Figure 1C ). The second round of search typically increased identifications by an average of 14% (5%-40%) while maintaining a stringent 1% FDR cutoff ( Figure S1A ; Table S1 ).
A total of 223 non-specifically bound peptides (negative controls) were identified by immunopurification from untransduced B721.221 cells or beads lacking antibody and represented $3% of all peptide identifications (Table S1A) . After filtering for these non-specific binders, we identified between 900 and 3550 unique peptides by LC-MS/MS for each HLA allele (median 1,505) ( Figure 1D ). Variation in surface presentation of HLA molecules on B721.221 cells, as compared to primary lymphocytes, appeared to explain most of the variation in observed peptide counts ( Figure S1B ). For common alleles (population frequency >1%), 74% percent of peptides were not reported in the Immune Epitope Database (IEDB); for rare alleles, nearly 100% were unreported ( Figure S1C) .
A high degree of peptide overlap was observed between biological replicates ($70%) and a previously reported B cell HLA-peptide dataset ( Figure S1D ) (Bassani-Sternberg et al., 2015) . A median of 92% of presented peptides were unmodified, and 5% were modified, of which 3% were phosphorylated, and the remainder were consistent with oxidation, deamidation, and other handling artifacts ( Figure S1E ) (Berg et al., 2006) . Comparisons among MS peptides and allele-matched synthetic peptides that were assigned as binders by IEDB (measured affinity < 500 nM; Figures 1E and 1F; Experimental Procedures) revealed only negligible peptide sequence biases related to our experimental procedures. The predicted MS observability of the HLA peptides and frequencies of individual amino acids between MS and IEDB peptides were highly similar, aside from underrepresentation of cysteine (Figures 1E and 1F) . Free cysteine, which interferes with precursor fragmentation during LC-MS/MS, is underrepresented in other MS-based HLA-peptide datasets (Bassani-Sternberg et al., 2015; Trolle et al., 2016) (Figure S1F ). We recovered cysteine-containing peptides when a third round of database search accounted for cysteinylation (Table S1C) .
Mono-allelic MS-Derived Repertoires Reveal Motifs
Underrepresented in IEDB HLA-binding affinities of peptides sequenced with our LC-MS/ MS platform were predicted with NetMHCpan ( Figure 2A ) and assessed in terms of their length distributions ( Figure 2B ). For nearly every allele, most MS peptides scored <500 nM; however, most alleles also exhibited populations of peptides with poor predicted binding scores, suggesting that our data included motifs underrepresented in the NetMHCpan training set. Indeed, comparison of MS and IEDB peptides showed significant differences in amino acid frequencies at specific positions. For instance, enrichments of isoleucine, valine, and leucine (p < 1 3 10 À5 , chi-square test) were often observed at positions 5-7, suggesting the presence of secondary anchors ( Figure 2C and Figures S2A-S2C ). This was true for both sparsely studied alleles, such as HLA-A*02:07, and well-studied alleles, such as HLA-A*68:02 and HLA-B*57:01. We also noted specific alleles with length preferences not captured in IEDB, such as HLA-A*31:01 and HLA-B*51:01, which bind high proportions of 11-mers and 8-mers, respectively ( Figure 2B ). To visualize the dominant and subdominant motifs within our data and among IEDB ''binders'' (measured affinity < 500 nM), we defined an entropy-weighted peptide distance and plotted the peptides in two-dimensional space such that ''similar'' peptides would be clustered closely and dissimilar peptides distantly (Experimental Procedures, Figure 2D and Figure S2D ). In this manner, we discovered patterns not immediately evident by (E) To evaluate LC-MS/MS bias, we calculated the ''MS observability index,'' as measured by the ESP algorithm (Fusaro et al., 2009) , for IEDB (blue) and MS (orange) peptide datasets. Distributions of the MS observability are displayed. (F) Amino acid frequencies within peptides reported in our single-allele dataset are compared to amino acid frequencies in peptides reported in IEDB. See also Figure S1 . conventional sequence logo visualizations. Notably, MS-defined peptides clustered more closely to each other than to IEDB peptides themselves ( Figure S2E ), which suggests that MS recovers stronger binding motifs compared to a greater preponderance of weak binding peptides in the IEDB binder sets. Moreover, we found multiple peptide clusters that were highly enriched in MS relative to IEDB ( Figures S2F and S2G ), reflecting unique information in the MS datasets. MS technology-related biases did not appear to underlie these patterns: a similar analysis focused on only the subset of peptides from MS or IEDB with physicochemical properties favorable for MS detection revealed similar distances and clustering patterns ( Figures S2H and S2I) (Eyers et al., 2011; Fusaro et al., 2009; Muntel et al., 2015; Searle et al., 2015) .
To experimentally validate these motifs, we selected sequences from clusters that were enriched within the MS datasets but that scored only within the bottom 10% when MS hits were evaluated by NetMHCpan 2.8 (Experimental Procedures). By competitive peptide-binding assays, 32 of 33 peptides were confirmed to be strong binders (median IC 50 < 14 nM), even (D) MS 9-mer peptides (orange) compared to IEDB 9-mer peptides (blue). Non-metric multidimensional scaling (NMDS) was used for visualization of pairwise peptide distances in two dimensions for each analyzed HLA allele. Peptide distance was defined on the basis of sequence similarity (Kim et al., 2009 ). The size of each circle corresponds to the NetMHCpan-predicted affinity score of the corresponding peptide. Synthesized peptides for 4/5 alleles are marked in and are numbered per the corresponding line in the table of measured and predicted binding affinities (for HLA-B35:01, see Figure S2J ). (E) MS peptides scoring in the bottom 10% by NetMHCpan 2.8 were selected for experimental validation. See also Figure S2 .
though only 14 of 33 were predicted as binders by NetMHCpan 2.8 (Figures 2D and 2E; Figure S2J ).
Peptide Sequence Contexts Show a Distinct and Conserved Proteasomal Processing Signature
Because HLA-bound peptides have successfully undergone all processing steps-including proteasomal cleavage (Nielsen et al., 2005; Toes et al., 2001) , transporter for antigen presentation (TAP) transport (Burgevin et al., 2008) , and endoplasmic reticulum amino peptidase (ERAP)-mediated trimming (Evnouchidou et al., 2014; Saveanu et al., 2005; York et al., 2002 )-prior to presentation, eluted peptide datasets are ideal for understanding how protein sequence context contributes to peptide processing and presentation. Nevertheless, the state of the art in cleavage prediction, NetChop (Keş mir et al., 2002; Nielsen et al., 2005) , relies on a relatively small dataset of a few thousand HLA-bound peptides and focuses primarily on C-terminal cleavage. We sought to refine our understanding of processing rules by analyzing our large dataset of 24,000 allele-specific MS peptides and finding motifs in the upstream and downstream flanking sequences, as well as within the HLA-binding peptide. We first focused on the sequence context around each HLA peptide within its source protein, which is not confounded by HLA binding ( Figure 3A) . Upstream of the peptide, at the first position (''U1''), arginine and lysine were highly enriched (relative to peptide decoys, consisting of random proteome 9-mers matched for their first two and last two amino acids), indicating a strong tryptic-like specificity at the N terminus (Figure 3A) . Downstream of the peptide, arginine and lysine were also enriched in the first position (''D1'') (which suggests that peptides are trimmed at the C terminus after a tryptic-like cleavage that occurs after these basic residues), and acidic residues were depleted in this position. In addition, there was an enrichment of alanine at the U1 and D1 positions. A strong depletion of proline at both termini was observed to extend 3-5 residues upstream and downstream, which may relate to proline's conformational rigidity. There was a very strong preference for peptides arising from the exact C terminus (labeled with a dash in Figure 3A ) of their host protein, where only a single cleavage event is required. By comparing amino acid frequencies upstream, within, and downstream of each peptide, we also observed depletion of ''cleavable'' amino acids (K, R, and A) and enrichment of ''non-cleavable'' proline within peptides ( Figure 3B ). Thus, avoidance of internal cleavage appears to be a key feature of HLA ligands. Finally, we considered whether protein sequence features, such as alpha helices and beta strands, might influence processing potential (Figure S3A) . LC-MS/MS peptides were twice as likely as genematched decoys to arise from signal peptide sequences; other features were significant but did not show an effect size greater than ±15%.
To explore whether the processing signature was likely to be generalizable, we analyzed the gene expression of the proteasome and the immunoproteasome; both were expressed in B721.221 B cells at proportions comparable to those in blood and epithelial cancers included in the cancer genome atlas (TCGA) ( Figure S3B ). When we examined the HLA-bound peptide repertoires previously recovered from cells of other lineages, including breast and colon cancer cells (Bassani-Sternberg et al., 2015) , fibroblasts (Bassani-Sternberg et al., 2015) , HeLa cells , and peripheral blood mononuclear cells (Caron et al., 2015) (Figures 3C-3G ), all the key features observed for B721.221 cells were likewise consistently observed for these other cell types. Applying this same analytic approach to reported class II peptides isolated from dendritic cells (Mommen et al., 2016) (MUTZ3 cell line), we observed a starkly different signature exhibiting preference for hydrophobic residues in the D1 position and a lack of the previously observed associations for lysine, arginine, and alanine ( Figure 3H ). Finally, we note that the HLA class I signature that we derived only modestly resembled that obtained by comparison of peptides with high versus low NetChop scores. Our analyses thus identify a common HLA class I cleavage signature that dramatically differs from that predicted by a widely used tool.
Although HLA-class-I-bound peptides are typically thought to be cleanly ''tucked'' within the HLA class I binding groove, a recent crystal structure and the detection of nested peptide sets within our dataset (8% of total peptides; Table S3 ) motivated us to explore whether some peptides might be bound with overhang. We hypothesized that if long isoforms of nested sets overhang, then the additional amino acids need not provide new anchors. On the other hand, if both short and long isoforms bind in tucked conformation, then extensions force the binding register to shift, and only certain amino acid additions can be tolerated. We observed that long isoforms indeed gain suitable new anchor sites (providing binding potential on par with the short isoforms); random amino acid extensions of short isoforms have uniformly worse binding potential ( Figure 3J ). This suggests that most peptides bind in the canonical tucked conformation.
Gene Expression and Binding Affinity Demonstrate a Simple, Multiplicative Relationship
In addition to the derivation of peptide binding and cleavage rules, as shown above, we also systematically evaluated the relative roles of gene expression, source-protein localization, and other source-protein characteristics to peptide presentation.
First, we evaluated the impact of gene expression. Peptide presentation is statistically associated with expression (RNA and protein) (Bassani-Sternberg et al., 2015; Juncker et al., 2009) ; however, there remains a lack of a standard approach for weighing expression against affinity during epitope prioritization. As a result, expression is routinely ignored in epitope selection or treated as a binary variable (Linnemann et al., 2015) . To clarify this relationship, we binned each of our MS peptides by source transcript(s) RNA-Seq expression and NetMHCpan-predicted affinity. We also binned random 9-mers from the genome, enabling the calculation of relative enrichment ratios ( Figure 4A ). This revealed a multiplicative relationship between expression and affinity, in which a 10-fold increase in expression could approximately compensate for a 90% decrease in binding potential. To rule out the possibility that this finding might be an artifact of MS detection limits, we compared the peptides with the highest versus lowest MS signal intensity and compared them in terms of RNA-Seq expression and predicted affinity. Lowintensity binders had lower expression and weaker affinity, showing that MS detection is not simply reflecting underlying protein abundance but also reflects relative binding strength ( Figure 4B ). Although a simple kinetic model of peptide on-and off-rates may have predicted this, limitations in expression data quality and depth and the use of multi-allelic data (for which prediction of affinity is more difficult) have previously obscured this finding. The presence of multiple upstream open reading frames in the 5 0 UTR of a transcript is associated with reduced presentation potential for its associated peptides ( Figure 4C ), suggesting that accurate measurements of translational efficiencies may enhance epitope selection further. (I) Percent change in amino acid frequency of top-scoring peptides (top 25%) compared to bottom-scoring peptides (bottom 25%) among 1,000,000 random proteome 9-mers evaluated by NetChop (Saxová et al., 2003) . Color coding indicates directionality and magnitude of percent change (see key). (J) Distribution of predicted affinities for the short isoforms (red) and long isoforms (yellow) of nested sets as well as for simulated long isoforms (random amino acids added at the beginning or end of the short isoforms). See also Figure S3 .
Source-Protein Localization and Sequence Features Show Significant, but Modest, Predictive Value
To determine whether the HLA class I processing pathway has cellular localization biases, we investigated whether there was enrichment in protein localization in our MS peptides relative to random 9-mer decoys from protein-coding genes ( Figure 4D , left) and relative to expression-matched 9-mer decoys (Figure 4D, right) . Without controlling for expression, we found that (E) The ratio of observed to expected peptides at each distance lag from the source protein N terminus (blackline). The expected counts were determined under the assumption that each peptide was equally likely to have arisen from any position in its source protein. Frequent premature translation abortion would be expected to create an N-terminal bias (dashed red line). (F) Observed versus expected HLA-peptide counts (determined from expression-matched decoys) as a function of source protein instability index (Guruprasad et al., 1990) . P values were calculated by t test. (Behrends et al., 2010; Christianson et al., 2011 Sowa et al., 2009 , each yielding a set of 50-100 high-confidence interacting proteins for a given bait (usually a known protein-turnover-pathway gene) were scored according to their enrichment for LC-MS/MSobserved peptides, here depicted as a histogram. Each block corresponds to one experiment and is colored according to the directionality and significance (chisquare test) of the enrichment (see key). The bait protein used in outlier experiments (SQSTM1, PIK3C3, and OTUD4) is marked along with the corresponding p value. See also Figure S4 . the differences were dramatic: secreted proteins showed an unexpected enrichment. However, the expression-corrected analysis eliminated most of these differences (aside from a persistent enrichment of peptides from proteins associated with the late endosome). Lack of expression correction may help to explain why previous analyses of this question have reached inconsistent conclusions (Bassani-Sternberg et al., 2015; Rock et al., 2014) .
Studies of peptide presentation kinetics have suggested that specialized pathways specifically target aborted translation products and misfolded proteins (Bourdetsky et al., 2014; Yewdell, 2011) . Consistent with recent analyses (Bourdetsky et al., 2014; Kim et al., 2013 ), we did not see an enrichment of peptides at the N-termini of their source proteins ( Figure 4E ), which would be expected if a meaningful fraction of peptides arose from aborted translation products. We also considered whether peptides from proteins with a high instability index (Guruprasad et al., 1990) or a high fraction of intrinsically disordered sequence (Experimental Procedures) were enriched in our MS data (Figures 4F and 4G) because we supposed that these would be more likely to trigger an unfolded protein response. The opposite trend was observed, suggesting either our measures of ''foldability'' were insufficient or that other unobserved variables potentially confound the signal.
Finally, we considered whether pathways of normal protein turnover were tied to presentation likelihood. The count of ubiquitination sites (previously observed in KG-1, Jurkat, or MM1S cells (Krö nke et al., 2015; Krö nke et al., 2014; Udeshi et al., 2012 Udeshi et al., , 2013 , was positively associated with HLA-peptide presentation, consistent with the known role for ubiquitin in delivering proteins to the proteasome ( Figure 4H ). Additionally, we queried a collection of 200 IP-MS/MS experiments, each profiling the physical interaction partners of a protein involved in deubiquitination, autophagy, or ER-associated degradation (Behrends et al., 2010; Christianson et al., 2011; Sowa et al., 2009) (Figure 4I ). Most of these gene sets were positively enriched in our data. Several outliers include PIK3C3, ATG12, and OTUD4, whose interaction partners were most strongly enriched. Meanwhile, the interaction partners of the autophagosome cargo protein SQSTM1 were most depleted. Collectively, these analyses may help to point to turnover pathways with privileged access to the HLA presentation pathway.
Multivariate Models Quantify the Predictive Contributions of Distinct Processing Steps
Given the consistent patterns for cleavability and expression on presented peptide sequences, we sought to determine whether integrating multiple variables into a single predictor would improve epitope selection accuracy. To measure model performance, we assessed our ability to discern MS peptides among a 999-fold excess of decoy peptides; the top-scoring 0.1% of peptides were selected as positives. Because there are approximately 10 million 9-mers in the human proteome, and each allele presents approximately 10,000 of these, the 1:1000 ratio closely mimics the reality of the epitope selection problem. This positive predictive value (PPV) metric, which measures the percentage of predicted positives that were indeed observed in the MS, contrasts with the standard AUC value (area under receiver operator characteristic curve), which integrates performance over all possible target:decoy ratios and thus considers unrealistic scenarios in the final score (Experimental Procedures and Figure S4 ).
Averaging across 16 alleles, an affinity-only model (per NetMHCpan, model ''A'') achieved a PPV of 28% ( Figure 5A ; see Table S4A for individual allele results). A stability-only model (NetMHCPanStab (Jørgensen et al., 2014) , model ''S'') performed nearly as well; however, joint prediction (model ''AS'') showed minor synergism. On the other hand, adding RNA-Seq or iBAQ-based (Ishihama et al., 2005) protein expression (models ''ASR'' and ''ASP'') improved PPV dramatically-to 39% and 47%, respectively. Adding cleavability prediction (per a de novo predictor trained on other MS data; Supplemental Experimental Procedures) provided a 7.9% boost (prediction with NetChop yields 3.1%). The incremental benefit of localization was less than 1%; other putative processing variables (stability index, disordered sequence content, count of ubiquitin sites, and sequence features such as alpha helices and beta strands) likewise showed incremental improvements less than 1%.
By exhaustively testing all possible predictor combinations (Table S4A) , we found the order of variable addition that added the most predictive value earliest; we tracked the incremental PPV improvement provided by each variable and assigned this as the variable's ''explanatory contribution'' ( Figure 5B ). Affinity and expression dominate the analysis, although notably, iBAQbased protein expression provided negligible contribution beyond RNA-Seq. For the 45% of MS peptides that were missed in the full model, it was not known how much this related to the suboptimal quality of the affinity and cleavage predictions, to unknown variables, or to stochasticity in the MS detection. The two genes with the most false negative calls per unit length were ubiquitin B and C, which suggests that improved understanding of protein turnover dynamics may be a key missing component.
De Novo Predictors Based on Mono-allelic MS Data Perform Better Than Affinity-Trained Predictors
To define whether these collective findings could be used to develop improved epitope-presentation predictors, we developed two single-layer artificial networks for each of the 16 alleles ( Figure 5C ). The first, MSIntrinsic, was trained exclusively on our MS data and used peptide-intrinsic features only; the second, MSIntrinsicEC, additionally accounted for RNA-Seq expression and the cleavability of the protein sequence context (Experimental Procedures).
We evaluated performance of these models on internal and external datasets by using PPV and AUC. We found that MSIntrinsic and MSIntrinsicEC outperformed both NetMHC 4.0 and NetMHCpan 2.8 in a 5-fold cross validation by an average PPV of 20 and 30 percentage points, respectively (Table S4B) . Accordingly, despite the fact that all models achieved an average AUC > 0.98, MSIntrinsic and MSIntrinsicEC consistently reached higher true-positive rates at minimal false-positive rates; we note that performance plateaued at $500 training peptides ( Figures  S5A-S5C ). Most importantly, we predicted which peptides would be identified in the LC-MS/MS data of other groups (BassaniSternberg et al., 2015; Trolle et al., 2016) , which comprised observations from six alleles and seven cell lines. In comparison to that of NetMHC 4.0 and NetMHCpan 2.8, the positive predictive value for MSIntrinsic was 1.4-fold better on average and worse than NetMHC in only one instance; MSIntrinsicEC was 1.9-fold better on average ( Figure 5D ). MS bias did not appear to account for these changes: NetMHC-based predictors that additionally accounted for MS observability (ESP) score and cysteine count did not show appreciable improvement (Table S4F) . Thus, we expect that these approaches could roughly double the number of correct epitope identifications in a vaccine. In addition, we used our algorithms to predict immunogenic HIV epitopes (Llano et al., 2013) . Although the dataset is of modest size, the rank position of the top scoring HIV epitope was higher than both NetMHC predictors or equal to one of them for 9/12 alleles overlapping with our dataset.
Because our neural-network approach is closely modeled after NetMHC and because we did not outperform NetMHC when we trained and evaluated on IEDB peptides ( Figure S5D ), our advances are likely to reflect the underlying high quality of our MS data and conceptual advances in data integration, rather than changes in neural-network design. Our results thus demonstrate that large MS datasets of endogenous HLA-binding peptides can greatly improve our understanding of antigen-processing rules and the power of algorithms to predict which peptides will be presented by specific HLA alleles.
DISCUSSION
The majority of LC-MS/MS studies of the HLA peptidome have used cells expressing multiple HLA molecules, which requires peptides to be assigned to one of up to six class I alleles through the use of pre-existing bioinformatics predictors, or ''deconvolution'' (Bassani-Sternberg and Gfeller, 2016). Thus, peptides that do not closely match known motifs cannot confidently be reported as binders to a given HLA allele. By contrast, we used a rapid approach to generate a high-quality LC-MS/MS dataset of >24,000 endogenous peptides whose assignment to specific HLA alleles was unambiguous. Because we knew the allele assignment a priori, we greatly enhanced our analyses depth. We discovered allele-specific binding motifs and proteasomal cleavage rules and discerned the effects of transcript abundance on presentation. By training models on these data, we more effectively predicted presentation of endogenous peptides than we did with models trained on IEDB binding measurement.
Given the availability of our large dataset, we sought to quantify in a systematic and unbiased fashion the role of different factors in predicting HLA-presented peptides. Prior proteomic studies have inconsistently discerned associations between protein abundance and HLA-peptide presentation (BassaniSternberg et al., 2015; Hickman et al., 2004; Milner et al., 2006) . Although Bassani-Sternberg et al. provide convincing evidence of positive association between HLA-peptide presentation and source-protein expression, their analysis was limited by reliance on MS-based protein quantification that had a high amount of missing observations. Therefore, we utilized RNA sequencing, a genome-wide characterization with a very low limit of detection (< 1 PPM) and with far greater accessibility for expression analysis than comparable proteomic approaches. We conclude that gene expression is a highly predictive variable and is more productively captured with RNA-Seq than with MSbased proteomic quantitation. Moreover, we have presented an analytic framework that enables the joint use of expression and affinity as variables to select epitopes in a principled manner, which is highly implementable in routine epitope-selection efforts in clinical settings. (Bassani-Sternberg et al., 2015; Trolle et al., 2016) were used for comparing the positive predictive value of MSIntrinsic and MSIntrinsicEC against NetMHCpan 2.8 and NetMHC 4.0 in identifying presented peptides among a 999-fold excess of random decoy 9-mers. Peptides were excluded from the evaluation if they were highly likely to bind an allele other than the one being evaluated. See also Figure S5 .
The contribution of cleavability in our analyses was large but not dominant, suggesting that proteasomes and other endogenous peptidases have a promiscuous specificity or are difficult to predict (Toes et al., 2001) . Cellular localization played a weak role in presentation, indicating that HLA class I peptides are derived from endogenous proteins throughout the cell. The additional impact of stability prediction is modest, and affinitybased NetMHCpan outperforms stability-based NetMHCStab in a direct head-to-head. These results suggest that motifs learned from stability assays are not substantially different. Finally, we developed a neural network, MSIntrinsicEC, that integrates these different variables and improves prediction performance of endogenous peptides relative to neural networks trained on non-MS datasets (Andreatta and Nielsen, 2016; Hoof et al., 2009; Lundegaard et al., 2008 ). An open question is how additional data types (e.g., protein translation rates and modes of protein turnover), improved data quality, a larger collection of validated non-binding peptides, and more powerful machine-learning-based predictions would boost our ability to predict antigen presentation and immunological responses.
Our methodologies provide a path toward addressing challenges relating to HLA-peptide presentation. First, the application of our single HLA workflows to class II heterodimers should improve class II prediction because confident, allele-specific peptide-binding assignments can be made. Having a singleallele system is especially important for class II because the length distribution obscures the binding register, making deconvolution approaches more challenging. Second, a rapid pipeline should enable identification of HLA-associated peptides from patient-derived cell lines or primary tumor samples, providing a unique opportunity for more personalized therapies against cancer. Third, recent observations of CD8+ T cells targeting mutated antigens in tumors (Schumacher and Schreiber, 2015) have inspired cancer immunotherapy trials aimed at inducing personalized T cells responses targeting an individual's tumor. More effective prediction of HLA-associated peptides from a collection of candidate antigens should contribute to the improvement of personalized cancer vaccines.
Overall, we expect these advances in unbiased identification and prediction of endogenous HLA-associated peptides to impact all areas of immunology, especially the identification of antigens driving autoimmunity and the design of more effective vaccines for infections and cancer.
EXPERIMENTAL PROCEDURES
Cell Culture and HLA-Peptide Immunopurification We tested mono-allelic B cells generated by transduction of B721.221 cells with a retroviral vector coding a single class I HLA allele as described previously (Reche et al., 2006) 
Sequence Properties of MS-Identified Peptides Compared to IEDB
A curated set of previously identified class I HLA-bound peptides was downloaded from the Immune Epitope Database (IEDB) at http://www.iedb.org/ (accessed on 10/26/2015) (Vita et al., 2015) . For each allele, IEDB peptides with a measured affinity <500 nM were compared to MS peptides in terms of their length and positional amino acid frequencies. In addition, a metric was defined for the pairwise ''distance'' between 9-mers (a Hamming distance calculated with an amino acid substitution matrix [Kim et al., 2009] and inversely weighted according to positional entropy) and used for clustering MS and IEDB peptides in a two-dimensional representation. A machine-learning approach (Supplemental Experimental Procedures) identified peptides with motifs favored in the MS but that were poor-scoring according to NetMHCpan 2.8; the MHCbinding affinities for these peptides were determined by competitive binding per gel filtration protocol (Sidney et al., 2001 ).
Peptide Processing Analyses
For each MS hit, the upstream ten amino acids and downstream ten amino acids were determined. Sequence context was likewise determined for decoy peptides (100 per hit; selected randomly from the proteome and matched according to their first two and last two amino acids). Relative amino acid frequencies were determined at each position upstream and downstream of hits and decoys. Additional previously published MS datasets were analyzed in the same manner. For comparison, peptides with high and low NetChop scores (top 25% and bottom 25% of 1 million randomly selected sites in the genome) were compared, and the motif most favored by NetChop was derived.
Relationship between Expression and Affinity RNA was isolated from B721.221 cells expressing HLA-A*29:02, B*51:01, B*54:01, and B*57:01 (RNeasy mini kit, QIAGEN), processed to cDNA (Nextera XT kit; Smart-seq2 protocol), sequenced (HiSeq2500, Rapid Run mode; 50 bp paired-end), and aligned (bowtie2-2.2.1 (Langmead and Salzberg, 2012) ; UCSC hg19 annotation). We averaged transcript expression (RSEM-1.2.19 [Li and Dewey, 2011] ; GEO: GSE93315) across the four cell lines and made adjustments by dropping non-coding transcripts and rescaling TPM values to sum to one million. We determined expression of each peptide source protein by summing all transcripts containing the peptide.
Impact of Processing Pathways
MS peptides were compared to decoys (ten decoys per MS peptide; each from a different gene; matched per transcript expression) in terms of various features potentially related to peptide processing: UNIPROT localization (www.uniprot.org), distance from protein N terminus, source protein stability index (Guruprasad et al., 1990) , intrinsically disordered sequence content (http://d2p2.pro) (Oates et al., 2013) , count of known ubiquitination sites (Eichmann et al., 2014; Krö nke et al., 2015; Udeshi et al., 2012) , and physical interaction with known protein turnover regulators (Behrends et al., 2010) .
Development of New Epitope-Selection Algorithms
For each allele, we trained neural-network classifiers (one hidden layer with 50 units) (by using Theano (Theano Development Team, 2016) ; 5-fold crossvalidation) to differentiate MS 9-mers from random decoy 9-mers by using different input feature schemes: dummy encoding, BLOSUM62, PMBEC (Kim et al., 2009) , biochemical properties (Bremel and Homan, 2010) , and peptide-level features (Osorio et al., 2014) ; we averaged the results of these models to obtain a single prediction (called MSIntrinsic). We made a second prediction (MSIntrinsicEC) by adding expression and MS-trained cleavability. We validated performance on external data by measuring PPV (fraction of true MS peptides among the top-scoring 0.1%, where decoys are present at 999:1). For multi-allelic datasets, the evaluation excluded any MS peptides that obviously belonged to an HLA-A or HLA-B allele other than the one in question (e.g., when predicting for A01:01 for a cell line with genotype A01:01/A02:01/B35:01/B44:02, we excluded MS-observed peptides with NetMHCPan 2.8 scores worse than 1,000 nM for A01:01 and better than 150 nM for A02:01, B35:01, or B44:02).
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